Kymera Therapeutic

$31.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-1.11%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KYMR and other stocks, options, and ETFs commission-free!

About KYMR

Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics.

CEO
Nello Mainolfi
Employees
75
Headquarters
Watertown, Massachusetts
Founded
2015
Market Cap
1.47B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
435.16K
High Today
$31.93
Low Today
$29.94
Open Price
$31.09
Volume
451.15K
52 Week High
$91.92
52 Week Low
$25.43

KYMR Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

WTFCP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure